Adaptin Bio Updates on FDA Clearance of IND Application for APTN-101 in Glioblastoma

Source :: Wireless News. September 12, 2024
Publication Year :: 2024
Abstract: Adaptin Bio, a biotechnology company focused on developing precision cancer therapies with improved delivery to the brain and other tissues, has emerged from stealth with the announcement that FDA has [...]

Subjects :: T cells -- Health aspects
Brain tumors -- Health aspects
Cancer -- Care and treatment
Clinical trials -- Health aspects
Glioblastoma multiforme -- Health aspects
Business
Business, international
Telecommunications industry

Tools